Population-based Genetic Screening Beyond Newborns: What is the Role of Public Health?
This web page is archived for historical purposes and is no longer being maintained or updated.
The Office of Public Health Genomics
invites you to attend a special workshop sponsored by CDC University:
Monday, January 30, 2017
9:00 a.m. – 12:30 p.m.
CDC Chamblee Campus
The lack of universal screening for genetic conditions outside of newborn screening means that many individuals with conditions that could be treated pre-symptomatically are not identified until they show signs of disease. At this point interventions are often less effective. This course will focus on defining the role of public health in population-based screening outside of the newborn screening period and in addressing health disparities in the use of genomics in health care.
- Dr. Carla Cuthbert (Branch Chief, Newborn Screening and Molecular Biology Branch, National Center for Environmental Health)
- Dr. Sonja Rasmussen (Director, Division of Public Health Information Dissemination, Editor-in-Chief, Morbidity and Mortality Weekly Report, Center for Surveillance, Epidemiology, and Laboratory Services)
- Dr. Lisa Richardson (Director, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion)
- Dr. Stuart Shapira (Chief Medical Officer and Associate Director for Science, National Center on Birth Defects and Developmental Disabilities)
Why should I attend?
Millions of people have genetic changes that make them more likely to get cancer, heart disease, diabetes, or other chronic diseases. Universal genetic screening for these conditions can help find these people before they get sick so that they can take steps to protect their health.
What will I learn?
- Benefits and risks of population-based genetic screening for chronic conditions
- How screening could address health disparities in the use of genetics in health care
Join the discussion to address questions such as
- What role should public health play in population-based genetic screening for chronic conditions?
- If implemented, when and how can such screening be done?
- What lessons can be learned from other population-based screening programs, including newborn screening?
- How would screening affect health disparities?